The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia
- PMID: 20594384
- PMCID: PMC3314709
- DOI: 10.1017/S1041610210000876
The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia
Abstract
Background: Neuropsychiatric symptoms (NPS) affect almost all patients with dementia and are a major focus of study and treatment. Accurate assessment of NPS through valid, sensitive and reliable measures is crucial. Although current NPS measures have many strengths, they also have some limitations (e.g. acquisition of data is limited to informants or caregivers as respondents, limited depth of items specific to moderate dementia). Therefore, we developed a revised version of the NPI, known as the NPI-C. The NPI-C includes expanded domains and items, and a clinician-rating methodology. This study evaluated the reliability and convergent validity of the NPI-C at ten international sites (seven languages).
Methods: Face validity for 78 new items was obtained through a Delphi panel. A total of 128 dyads (caregivers/patients) from three severity categories of dementia (mild = 58, moderate = 49, severe = 21) were interviewed separately by two trained raters using two rating methods: the original NPI interview and a clinician-rated method. Rater 1 also administered four additional, established measures: the Apathy Evaluation Scale, the Brief Psychiatric Rating Scale, the Cohen-Mansfield Agitation Index, and the Cornell Scale for Depression in Dementia. Intraclass correlations were used to determine inter-rater reliability. Pearson correlations between the four relevant NPI-C domains and their corresponding outside measures were used for convergent validity.
Results: Inter-rater reliability was strong for most items. Convergent validity was moderate (apathy and agitation) to strong (hallucinations and delusions; agitation and aberrant vocalization; and depression) for clinician ratings in NPI-C domains.
Conclusion: Overall, the NPI-C shows promise as a versatile tool which can accurately measure NPS and which uses a uniform scale system to facilitate data comparisons across studies.
Conflict of interest statement
None.
Similar articles
-
The Brazilian version of the Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity in dementia.Int Psychogeriatr. 2013 Sep;25(9):1503-11. doi: 10.1017/S1041610213000811. Epub 2013 Jun 14. Int Psychogeriatr. 2013. PMID: 23763895 Free PMC article.
-
[In Alzheimer's disease, the clinical expression of behavioral and psychological signs and symptoms is early and specific of neuropathological stages].Encephale. 2010 Sep;36(4):314-25. doi: 10.1016/j.encep.2009.10.012. Epub 2009 Dec 3. Encephale. 2010. PMID: 20850603 French.
-
Clinician and caregiver agreement on neuropsychiatric symptom severity: a study using the Neuropsychiatric Inventory - Clinician rating scale (NPI-C).Int Psychogeriatr. 2014 Jul;26(7):1139-45. doi: 10.1017/S1041610214000295. Epub 2014 Mar 13. Int Psychogeriatr. 2014. PMID: 24622334
-
The Neuropsychiatric Inventory: assessing psychopathology in dementia patients.Neurology. 1997 May;48(5 Suppl 6):S10-6. doi: 10.1212/wnl.48.5_suppl_6.10s. Neurology. 1997. PMID: 9153155 Review.
-
Behavioral and psychological symptoms of dementia: a current focus for clinicians, researchers, and caregivers.J Clin Psychiatry. 2001;62 Suppl 21:3-6. J Clin Psychiatry. 2001. PMID: 11584987 Review.
Cited by
-
Electroconvulsive therapy for the acute management of severe agitation in dementia (ECT-AD): A modified study protocol.PLoS One. 2024 Jun 28;19(6):e0303894. doi: 10.1371/journal.pone.0303894. eCollection 2024. PLoS One. 2024. PMID: 38941338 Free PMC article. Clinical Trial.
-
Tau as a biomarker of cognitive impairment and neuropsychiatric symptom in Alzheimer's disease.Hum Brain Mapp. 2023 Feb 1;44(2):327-340. doi: 10.1002/hbm.26043. Epub 2022 Aug 14. Hum Brain Mapp. 2023. PMID: 36647262 Free PMC article.
-
Development of a Caregivers' Support Platform (Connected Health Sustaining Home Stay in Dementia): Protocol for a Longitudinal Observational Mixed Methods Study.JMIR Res Protoc. 2019 Aug 28;8(8):13280. doi: 10.2196/13280. JMIR Res Protoc. 2019. PMID: 31464187 Free PMC article.
-
Impact of three dementia-related behaviors on caregiver depression: The role of rejection of care, aggression, and agitation.Int J Geriatr Psychiatry. 2019 Jul;34(7):966-973. doi: 10.1002/gps.5097. Epub 2019 Apr 4. Int J Geriatr Psychiatry. 2019. PMID: 30897238 Free PMC article.
-
A review of current evidence for mild behavioral impairment as an early potential novel marker of Alzheimer's disease.Front Psychiatry. 2023 Apr 27;14:1099333. doi: 10.3389/fpsyt.2023.1099333. eCollection 2023. Front Psychiatry. 2023. PMID: 37293396 Free PMC article. Review.
References
-
- Alexopoulos GS, Abrams RC, Young RC, Shamoian CA. Cornell Scale for Depression in Dementia. Biological Psychiatry. 1988;23:271–284. - PubMed
-
- Ballard C, Day S, Sharp S, Wing G, Sorensen S. Neuropsychiatric symptoms in dementia: Importance and treatment considerations. International Review of Psychiatry. 2008;20:396–404. - PubMed
-
- Brodaty H, et al. Psychosis, depression and behavioral disturbances in Sydney nursing home residents: Prevalence and predictors. International Journal of Geriatric Psychiatry. 2001;16:504–512. - PubMed
-
- Camozzato AL, et al. Reliability of the Brazilian Portuguese version of the Neuropsychiatric Inventory (NPI) for patients with Alzheimer’s disease and their caregivers. International Psychogeriatrics. 2008;20:383–393. - PubMed
-
- Cohen-Mansfield J, Marx MS, Rosenthal AS. A description of agitation in a nursing home. Journal of Gerontology: Medical Sciences. 1989;44:M77–M84. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical